ACE inhibitor dosage at the time of listing predicts survival

Journal of Heart and Lung Transplantation

Volumn 19, Issue 2, 2000, Pages 127-133

  Berger, Rudolf ^a   Kuchling, Gerald ^b   Frey, Bernhard ^a   Kozanly, Ilyas ^a   Pacher, Richard ^a   Stanek, Brigitte ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FUROSEMIDE; GAMMA GLUTAMYLTRANSFERASE; LISINOPRIL; NITRATE; RAMIPRIL;

ADULT; AGED; ARTICLE; AUSTRIA; BLOOD PRESSURE; CONTROLLED STUDY; DATA BASE; DEATH; ELECTIVE SURGERY; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; ENALAPRIL; FEMALE; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; HUMANS; LISINOPRIL; MALE; MIDDLE AGED; PROGNOSIS; RAMIPRIL; SURVIVAL ANALYSIS;

EID: 0033983708     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(99)00124-2     Document Type: Article

References (27)

1. Gheorghiade M., Benatar D., Konstam M.A., Satudikes C.H., Bonow R.O. Pharmacotherapy for systolic dysfunction a review of randomized clinical trials . Am J Cardiol. 80:(8B):1997;14H-27H.
2. McDermott M.M., Lee P., Mehta S., Gheorghiade M. Patterns of ACE inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure. Clin Cardiol. 21:1998;261-268.
3. Luzier A.B., Forrest A., Adelman M., Hawari F.I., Schentag J.J., Izzo J.L. Jr. Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure. Am J Cardiology. 82:1998;465-469.
4. Slany J. Heart failure treatment the state of Austrian clinical practice - the Cor survey . Int J Clin Pharmacol. (Suppl. 94):1998;37-42.
5. Effects on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study. N Engl J Med. 316:1987;1429-1435.
6. Swedberg K., Kjekshus J., Snapinn S. Long-term survival in severe heart failure patients treated with enalapril. Eur Heart J. 20:1999;136-139.
7. Pacher R., Globits S., Bergler-Klein J., et al. Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages. Eur Heart J. 14:1993;273-278.
8. Pacher R., Stanek B., Globits S., et al. Effects of two different enalapril dosages on clinical, hemodynamic and neurohumoral response of patients with severe congestive heart failure. Eur Heart J. 17:1996;1223-1232.
9. Berger R., Stanek B., Hülsmann M., et al. Delayed effects of one-year treatment with low-dose as compared with high-dose enalapril on morbidity and mortality of patients with severe heart failure. J Clin Bas Cardiol. 1:1998;19-24.
10. Packer M, Poole-Wilson P, Armstrong P, et al. Comparative effects of low-dose versus high-dose lisinopril on survival and major events in chronic heart failure: the Assessment of Treatment with Lisinopril and Survival Study (ATLAS) (Abstr.) Eur Heart J 1998;19(suppl):142.
11. Husten L. ATLAS shows global undertreatment of heart failure (news). Lancet. 351:1998;1035.
12. Aaronson K.D., Schwartz J.S., Chen T., Wong K., Goin J.E., Mancini D.M. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 95:1997;2660-2667.
13. Cowburn P.J., Cleland J.G.F., Coats A.J.S., Komajda M. Risk stratification in chronic heart failure. Eur Heart J. 19:1998;696-710.
14. Cohn J.N., Johnson G.R., Shabetai R., et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ration, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. Circulation. 87:1993;V15-V6.
15. Keogh A.M., Baron D.W., Hickie J.B. Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol. 65:1990;903-908.
16. Pousset F., Issnard R., Lechat P., et al. Prognostic value of plasma endothelin-1 in patients with chronic heart failure. Eur Heart J. 18:1997;254-258.
17. Pacher R., Stanek B., Hülsmann M., et al. Prognostic impact of big endothelin-1 plasma concentrations as compared to invasive hemdodynamic evaluation in severe heart failure. J Am Coll Cardiol. 27:1996;633-641.
18. Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison. Eur Heart J. 19:1998;481-489.
19. Stanek B., Frey B., Hülsmann M., et al. Validation of big endothelin plasma levels compared to established neurohumoral markers in patients with severe chronic heart failure. Transpl Proc. 29:1997;595-596.
20. Hülsmann M., Stanek B., Frey B., et al. Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure. J Am Coll Cardiol. 32:1998;1695-1700.
21. Stelken A., Younis L., Jennison S., et al. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol. 27:1996;345-352.
22. Packer M. Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice? J Am Coll Cardiol. 28:1996;1323-1327.
23. Fonarow G.C., Stevenson L.W., Walden J.A., et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol. 30:1997;725-732.
24. Packer M., Bristow M.R., Cohn J.N., et al. The effect of carvediol on LV function and mortality in patients with chronic heart failure. N Eng J Med. 334:1996;1349-1355.
25. The Cardiac Insufficiency Bisoprolol Study (CIBIS II) a randomized trial . Lancet. 353:1999;9-13.
26. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure meta-analysis of individual data from 6500 patients in randomised trials . Lancet. 350:1997;1417-1424.
27. Cohn J.N. Nitrates in left ventricular dysfunction and congestive heart failure. Am J Cardiol. 81:(1A):1998;54A-56A.